News
-
-
-
PRESS RELEASE
Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch
Amoéba finalizes funding plan with a €10 million capital increase through share subscription warrants for future commercial and cosmetics business developments -
-
-
PRESS RELEASE
Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency
Amoéba successfully completes private placement and confirms target amount of capital increase. Anticipating future growth and financial ambitions. Detailed terms for operation to be released soon -
-
-
PRESS RELEASE
Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset
Amoéba transitions to an industrial biocontrol company, targets €40 million revenue by 2030. Monetizes Willa™ cosmetics asset. Provisional 2026 financial results revealed -